Pfizer Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2022
Total Assets: $197.21B
Liabilities Breakdown FY2022
Total Liabilities: $101.29B
Asset Breakdown
Total Assets: $197.21B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $416.0M | 0.2% |
| Accounts Receivable | $10.95B | 5.6% |
| Inventory | $8.98B | 4.6% |
| Property, Plant & Equipment | $16.27B | 8.3% |
| Goodwill | $51.38B | 26.1% |
| Intangible Assets | $43.37B | 22.0% |
| Other Assets | $65.84B | 33.4% |
Liabilities Breakdown
Total Liabilities: $101.29B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $6.81B | 6.7% |
| Long-Term Debt | $32.88B | 32.5% |
| Other Liabilities | $61.60B | 60.8% |